Clinical Trials Directory

Trials / Completed

CompletedNCT01060033

MRI (Including Spectroscopy and Fat-Saturations and Diffusion-Weighted Imaging) in Cervical Cancer

A Study of Novel Magnetic Resonance Imaging Sequences for Target Delineation and Prognostication in Cervical Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To detect differences in MR spectroscopy, diffusion weighted MR, diffusion tensor imaging (DTI) or dynamic contrast enhancement (DCE) MR imaging between primary cervical tumors and normal cervical tissue.

Detailed description

At our institution, all patients receiving external beam and/or brachytherapy as part of the treatment of primary cervical cancer receive CT, PET, and MRI simulation scans as standard of care. Brachytherapy patients also receive weekly T1/T2 weighted MR simulation scans as part of their treatment planning. We propose the use of additional MR sequences to the standard T1/T2 weighted MR simulation scans. The data obtained from these additional sequences will be used for improving tumor delineation and obtaining prognostic information.

Conditions

Interventions

TypeNameDescription
DEVICEMR Spectroscopy
DEVICEFat-Saturation and Diffusion-Weighted Imaging
DEVICEDynamic Contrast Enhancement MRI (MR-DCE)
DEVICEDiffusion Tensor Imaging (DTI)

Timeline

Start date
2010-11-01
Primary completion
2014-08-01
Completion
2014-08-01
First posted
2010-02-01
Last updated
2017-04-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01060033. Inclusion in this directory is not an endorsement.